FDA Approves FINGOLIMOD — Ascend Laboratories, LLC

Ascend Laboratories, LLC received FDA approval Tuesday for the generic version of Fingolimod Hydrochloride (Gilenya), potentially intensifying generic competition in the autoimmune market segment as patent protections for the brand-name drug begin to expire. The oral product is manufactured for major pharmaceutical marketing companies, signaling a significant shift in market access for patients as cost pressures increase for both payers and providers.